Encorafenib + cetuximab (EC) BREAKWATER Study Reveals Breakthrough in Treating BRAF V600E-Mutant Metastatic Colorectal Cancer Gastrointestinal 3 Mins Read The latest findings from the BREAKWATER study, a phase 3 clinical trial, have shown significant strides in improving treatment outcomes…
KRYSTAL-1: Adagrasib + Cetuximab Promise for KRASG12C Colorectal Cancer – Scott Kopetz, MD [AACR 2024] Colorectal 3 Mins Read …The field of oncology is continuously evolving, with research focusing on developing more effective and personalized treatment modalities. One such…
